Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Should You Buy Novartis Stock Before October 28?
Economy

Should You Buy Novartis Stock Before October 28?

Last updated: October 10, 2025 6:17 pm
Share
Should You Buy Novartis Stock Before October 28?
SHARE

This year, Novartis (NVS), a leading global healthcare firm based in Switzerland, is experiencing robust growth fueled by effective pipeline management, favorable regulatory outcomes, premium licensing agreements, shareholder returns, and positive market perceptions. The company’s stock has increased by 36.3% year-to-date, significantly surpassing overall market performance.

After the 2023 spinoff of Sandoz (SDZNY), Novartis has repositioned itself as a dedicated innovative medicines entity, concentrating on high-value therapeutic sectors.

  • The Chart’s Flashing a New Warning: META Stock Could Tumble to $500 From Here

  • Trump Just Took a 10% Stake in Trilogy Metals. Should You Buy TMQ Stock Here?

  • I Told You How to Trade AMD Stock to $200. Now That It’s an ‘AI Hero,’ Here’s 1 Way to Play Its Next Move.

  • Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won’t find anywhere else.

The announcement of Novartis’ third-quarter earnings report is set for October 28, raising questions about whether the stock is a sound investment prior to the earnings release.

www.barchart.com

www.barchart.com

By concentrating on high-value innovative medicines, Novartis is reaping the rewards. Excluding Entresto, the company’s priority brands saw a 33% increase, suggesting that its new generation of drugs is successfully driving growth. In Q2, net sales jumped 11% year-over-year, with core earnings per share climbing 24% to $2.42.

During the earnings call, CEO Vas Narasimhan highlighted the robust performance of the company’s portfolio, especially its newer oncology, neurology, and cardiovascular offerings as key contributors to its impressive quarter. The oncology medication Kisqali emerged as a standout, surging 64% and achieving total prescription leadership in metastatic breast cancer. Narasimhan indicated that the upward trend of Kisqali suggests it is poised to become a multibillion-dollar growth driver in the coming decade.

See also  Alphabet Slides After Cloud Sales Fall Short of Expectations

Moreover, Kesimpta, Novartis’ self-administered treatment for multiple sclerosis (MS), rose 33% this quarter. Additionally, Pluvicto for prostate cancer rebounded strongly, increasing 30% post-approval of its new pre-tax indication in the U.S. The cholesterol-lowering medication Leqvio (inclisiran) also recorded an impressive 61% growth trajectory, on pace to exceed $1 billion in annual sales.

Entresto, Novartis’ leading heart failure drug, continues its consistent growth. The company has confirmed an anticipated loss of exclusivity (LoE) by mid-2025 in the U.S., due to ongoing litigation with one generic competitor. However, it remains a substantial global revenue contributor, particularly in Europe, China, and Japan, where patent protection lasts until 2026 and beyond, suggesting ongoing significant revenue generation throughout the decade.

TAGGED:BuyNovartisOctoberStock
Share This Article
Twitter Email Copy Link Print
Previous Article Report: Thune Betrays MAGA, Begs Trump Not to Lay Off Government Employees During Shutdown, Wastes Once-in-a-Lifetime Opportunity Report: Thune Betrays MAGA, Begs Trump Not to Lay Off Government Employees During Shutdown, Wastes Once-in-a-Lifetime Opportunity
Next Article How to Style Knee-High Boots—7 Fall-Ready Outfit Ideas How to Style Knee-High Boots—7 Fall-Ready Outfit Ideas
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Manchester City wish Virat Kohli on Test retirement with memories of his & Anushka Sharma’s visit [In Picture]

English football club Manchester City recently took to social media to extend their congratulations to…

May 12, 2025

Good Omens Season 3 Potential Release Date, News and Rumours

The highly acclaimed Amazon Prime Video series Good Omens, based on the popular fantasy book,…

February 12, 2025

Cardiologist in charge of YouTube Health fights misinformation

YouTube plays a crucial role in providing health information to people worldwide, according to Garth…

November 29, 2024

Moon Or Mars? NASA’s Future At A Crossroads Under Trump 2.0

Washington: Is NASA still on a path to the Moon, or is the next big…

February 20, 2025

Prodigy on the keys and skis

Being a talented ski racer is impressive, but being able to excel in both skiing…

August 31, 2024

You Might Also Like

This NYSE-Listed Food Company Aims to Stack .2 Billion in Bitcoin
Economy

This NYSE-Listed Food Company Aims to Stack $1.2 Billion in Bitcoin

October 10, 2025
Adidas to Enter Safety Footwear in 2026 With New ‘Pro Work’ Line
Economy

Adidas to Enter Safety Footwear in 2026 With New ‘Pro Work’ Line

October 10, 2025
Elon Musk and former Twitter execs agree to settle 8 million lawsuit
Economy

Elon Musk and former Twitter execs agree to settle $128 million lawsuit

October 10, 2025
I’m a Financial Advisor: People Always Regret Doing These 5 Things With Their Roth IRA
Economy

I’m a Financial Advisor: People Always Regret Doing These 5 Things With Their Roth IRA

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?